Kelly Scientific analysis indicates that the current medical aesthetic industry is worth .3 billion for both service and product revenue. Over the next five years a CAGR of 5.5% is expected and the market will hit .6 billion in 2022. Currently, invasive aesthetic procedures generated revenues of over .8 billion, annually. Kelly Scientific analysis indicate that by 2022, invasive aesthetic procedures will grow at a CAGR of 4.3%. Non-invasive procedures generate approximately .7 billio

This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. Kelly Scientific analysis indicates that the global regenerative medicine market was worth .9 billion in 2016 and will grow to over .7 billion by 2021, with a CAGR of 23.3% between this time frame. Within this market, the stem cell industry w

Within the cancer therapeutics space, which today is worth over 0 billion globally, immunotherapeutic drugs have gained worldwide acceptance. This is because they are targeted therapeutics that have high specificity for cancer cells. Today, cancer immunotherapy drugs have captured nearly 50% of the overall oncology drugs market, generating about billion in 2016 alone and are forecast to surpass 0 billion in 2022. This report describes the evolution of such a huge market in 20 chapters